Cardiac calcifications are more prevalent in children receiving hemodialysis than peritoneal dialysis

Clinical Nephrology

Volumn 81, Issue 4, 2014, Pages 231-237

  Srivaths, Poyyapakkam ^a   Krishnamurthy, Rajesh ^b   Brunner, Lori ^c   Logan, Barbara ^c   Bennett, Michael ^c   Ma, Qing ^c   VanDeVoorde, Rene ^c   Goldstein, Stuart L ^c  

^a Renal Section   (United States)

^b BAYLOR COLLEGE OF MEDICINE   (United States)

^c CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

Author keywords

Cardiovascular; Children; Dialysis

Indexed keywords

ALBUMIN; C REACTIVE PROTEIN; CALCIFEDIOL; CALCITRIOL; CALCIUM; CHOLESTEROL; FIBROBLAST GROWTH FACTOR 23; INTERLEUKIN 6; INTERLEUKIN 8; PARATHYROID HORMONE; PHOSPHORUS; SEVELAMER;

ADOLESCENT; ADULT; AGATSTON SCORE; AGE; ALBUMIN BLOOD LEVEL; ARTICLE; CALCIFICATION; CALCIUM BLOOD LEVEL; CARDIAC CALCIFICATION; CARDIOVASCULAR RISK; CHILD; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CROSS-SECTIONAL STUDY; END STAGE RENAL DISEASE; FEMALE; HEMODIALYSIS; HEMODIALYSIS PATIENT; HUMAN; INFLAMMATION; KIDNEY FUNCTION; MAINTENANCE THERAPY; MALE; MULTIDETECTOR COMPUTED TOMOGRAPHY; PARATHYROID HORMONE BLOOD LEVEL; PERITONEAL DIALYSIS; PHOSPHATE BLOOD LEVEL; PRESCHOOL CHILD; PREVALENCE; QUANTITATIVE ANALYSIS; RENAL OSTEODYSTROPHY; RISK FACTOR; SCHOOL CHILD; TIME; TREATMENT DURATION;

ADOLESCENT; AGE FACTORS; C-REACTIVE PROTEIN; CALCINOSIS; CARDIOVASCULAR DISEASES; CHILD; CHILD, PRESCHOOL; FEMALE; FIBROBLAST GROWTH FACTORS; HUMANS; INTERLEUKIN-6; INTERLEUKIN-8; MALE; PERITONEAL DIALYSIS; PHOSPHORUS; PREVALENCE; RENAL DIALYSIS; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; YOUNG ADULT;

EID: 84896531525     PISSN: 03010430     EISSN: None     Source Type: Journal    
DOI: 10.5414/CN108178     Document Type: Article

References (30)

1. Parekh RS, Carroll CE, Wolfe RA, Port FK. Cardiovascular mortality in children and young adults with end-stage kidney disease. J Pediatr. 2002; 141: 191-197. CrossRef PubMed
2. Kidney Disease: Improving Global Outcomes (KDIGO) CKD-MBD Work Group. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD). Kidney Int Suppl. 2009; (Suppl): S1-S130. PubMed
3. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM. Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int. 2007; 71: 438-441. CrossRef PubMed
4. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P. Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int. 2005; 68: 1815-1824. CrossRef PubMed
5. Civilibal M, Caliskan S, Adaletli I, Oflaz H, Sever L, Candan C, Canpolat N, Kasapcopur O, Kuruoglu S, Arisoy N. Coronary artery calcifications in children with end-stage renal disease. Pediatr Nephrol. 2006; 21: 1426-1433. CrossRef PubMed
6. Shroff RC, Donald AE, Hiorns MP, Watson A, Feather S, Milford D, Ellins EA, Storry C, Ridout D, Deanfield J, Rees L. Mineral metabolism and vascular damage in children on dialysis. J Am Soc Nephrol. 2007; 18: 2996-3003. CrossRef PubMed
7. Arora S, Mookadam F, Srivathsan K. Interventional management of atrial fibrillation. Expert Rev Cardiovasc Ther. 2010; 8: 949-958. CrossRef PubMed
8. Srivaths PR, Silverstein DM, Leung J, Krishnamurthy R, Goldstein SL. Malnutrition-inflammation-coronary calcification in pediatric patients receiving chronic hemodialysis. Hemodial Int. 2010; 14: 263-269. CrossRef PubMed
9. Srivaths PR, Goldstein SL, Silverstein DM, Krishnamurthy R, Brewer ED. Elevated FGF 23 and phosphorus are associated with coronary calcification in hemodialysis patients. Pediatr Nephrol. 2011; 26: 945-951. CrossRef PubMed
10. Noordzij M, Korevaar JC, Bos WJ, Boeschoten EW, Dekker FW, Bossuyt PM, Krediet RT. Mineral metabolism and cardiovascular morbidity and mortality risk: peritoneal dialysis patients compared with haemodialysis patients. Nephrol Dial Transplant. 2006; 21: 2513-2520. CrossRef PubMed
11. Winchester JF, Rotellar C, Goggins M, Robino D, Rakowski TA, Argy WP. Calcium and phosphate balance in dialysis patients. Kidney Int Suppl. 1993; 41: S174-S178. PubMed
12. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte M Jr, Detrano R. Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol. 1990; 15: 827-832. Cross-Ref PubMed
13. van Husen M, Fischer AK, Lehnhardt A, Klaassen I, Möller K, Müller-Wiefel DE, Kemper MJ. Fibroblast growth factor 23 and bone metabolism in children with chronic kidney disease. Kidney Int. 2010; 78: 200-206. CrossRef PubMed
14. Gutiérrez OM, Mannstadt M, Isakova T, Rauh-Hain JA, Tamez H, Shah A, Smith K, Lee H, Thadhani R, Jüppner H, Wolf M. Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis. N Engl J Med. 2008; 359: 584-592. Cross-Ref PubMed
15. Gallieni M, Caputo F, Filippini A, Gabella P, Giannattasio M, Stingone A, Farina M; ROCK-PD Study Investigators. Prevalence and progression of cardiovascular calcifications in peritoneal dialysis patients: A prospective study. Bone. 2012; 51: 332-337. CrossRef PubMed
16. Cozzolino M, Stucchi A, Rizzo MA, Brenna I, Elli F, Ciceri P, Bover J, Cusi D, Gallieni M. Phosphate control in peritoneal dialysis. Contrib Nephrol. 2012; 178: 116-123. CrossRef PubMed
17. Sozeri B, Mir S, Kara OD, Levent E. When does the cardiovascular disease appear in patients with chronic kidney disease? Pediatr Cardiol. 2010; 31: 821-828. CrossRef PubMed
18. Shroff RC, McNair R, Figg N, Skepper JN, Schurgers L, Gupta A, Hiorns M, Donald AE, Deanfield J, Rees L, Shanahan CM. Dialysis accelerates medial vascular calcification in part by triggering smooth muscle cell apoptosis. Circulation. 2008; 118: 1748-1757. CrossRef PubMed
19. Mathew S, Lund RJ, Strebeck F, Tustison KS, Geurs T, Hruska KA. Reversal of the adynamic bone disorder and decreased vascular calcification in chronic kidney disease by sevelamer carbonate therapy. J Am Soc Nephrol. 2007; 18: 122-130. CrossRef PubMed
20. Isakova T, Gutiérrez OM, Chang Y, Shah A, Tamez H, Smith K, Thadhani R, Wolf M. Phosphorus binders and survival on hemodialysis. J Am Soc Nephrol. 2009; 20: 388-396. CrossRef PubMed
21. Kuro-o M. Overview of the FGF23-Klotho axis. Pediatr Nephrol. 2010; 25: 583-590. CrossRef PubMed
22. Razzaque MS. The FGF23-Klotho axis: endocrine regulation of phosphate homeostasis. Nat Rev Endocrinol. 2009; 5: 611-619. CrossRef PubMed
23. Jean G, Bresson E, Terrat JC, Vanel T, Hurot JM, Lorriaux C, Mayor B, Chazot C. Peripheral vascular calcification in long-haemodialysis patients: associated factors and survival consequences. Nephrol Dial Transplant. 2009; 24: 948-955. CrossRef PubMed
24. Balci M, Kirkpantur A, Gulbay M, Gurbuz OA. Plasma fibroblast growth factor-23 levels are independently associated with carotid artery atherosclerosis in maintenance hemodialysis patients. Hemodial Int. 2010; 14: 425-432. CrossRef PubMed
25. Gutiérrez OM, Januzzi JL, Isakova T, Laliberte K, Smith K, Collerone G, Sarwar A, Hoffmann U, Coglianese E, Christenson R, Wang TJ, deFilippi C, Wolf M. Fibroblast growth factor 23 and left ventricular hypertrophy in chronic kidney disease. Circulation. 2009; 119: 2545-2552. Cross-Ref PubMed
26. Mirza MA, Larsson A, Melhus H, Lind L, Larsson TE. Serum intact FGF23 associate with left ventricular mass, hypertrophy and geometry in an elderly population. Atherosclerosis. 2009; 207: 546-551. CrossRef PubMed
27. Faul C, Amaral AP, Oskouei B, Hu MC, Sloan A, Isakova T, Gutiérrez OM, Aguillon-Prada R, Lincoln J, Hare JM, Mundel P, Morales A, Scialla J, Fischer M, Soliman EZ, Chen J, Go AS, Rosas SE, Nessel L, Townsend RR, et al. FGF23 induces left ventricular hypertrophy. J Clin Invest. 2011; 121: 4393-4408. CrossRef PubMed
28. Coburn JW. Mineral metabolism and renal bone disease: effects of CAPD versus hemodialysis. Kidney Int Suppl. 1993; 40: S92-S100. PubMed
29. Wang AY, Lai KN. The importance of residual renal function in dialysis patients. Kidney Int. 2006; 69: 1726-1732. CrossRef PubMed
30. Viaene L, Bammens B, Meijers BK, Vanrenterghem Y, Vanderschueren D, Evenepoel P. Residual renal function is an independent determinant of serum FGF-23 levels in dialysis patients. Nephrol Dial Transplant. 2012; 27: 2017-2022. CrossRef PubMed